scholarly journals Analysis of Telavancin In Vitro Activity Tested Against a USA Collection of Staphylococcus aureus Clinical Isolates Causing Hospital-Acquired Pneumonia (2013–2014)

2015 ◽  
Vol 2 (suppl_1) ◽  
Author(s):  
Rodrigo E. Mendes ◽  
Helio S. Sader ◽  
Robert K. Flamm ◽  
Jennifer I. Smart ◽  
David J. Farrell ◽  
...  
Drugs ◽  
1995 ◽  
Vol 49 (Supplement 2) ◽  
pp. 230-232 ◽  
Author(s):  
S. Nishijima ◽  
S. Namura ◽  
H. Akamatsu ◽  
S. Kawai ◽  
Y. Asada ◽  
...  

2011 ◽  
Vol 64 (8) ◽  
pp. 559-562 ◽  
Author(s):  
Chunguang Sun ◽  
Matthew E Falagas ◽  
Rui Wang ◽  
Drosos E Karageorgopoulos ◽  
Xuhong Yu ◽  
...  

1994 ◽  
Vol 47 (4) ◽  
pp. 507-509 ◽  
Author(s):  
YOSHIYUKI KAWAKAMI ◽  
CHIZUMI FURUWATARI ◽  
TAKAYUKI AKAHANE ◽  
YUKIE OKIMURA ◽  
KEN''ICHI FURIHATA ◽  
...  

2014 ◽  
Vol 67 (5) ◽  
pp. 369-371 ◽  
Author(s):  
Yu Xu-hong ◽  
Matthew E Falagas ◽  
Wang Dong ◽  
Drosos E Karageorgopoulos ◽  
Lin De-feng ◽  
...  

2002 ◽  
Vol 46 (6) ◽  
pp. 1989-1992 ◽  
Author(s):  
James A. Karlowsky ◽  
Laurie J. Kelly ◽  
Ian A. Critchley ◽  
Mark E. Jones ◽  
Clyde Thornsberry ◽  
...  

ABSTRACT All of the isolates of Staphylococcus aureus (n = 317), Enterococcus species (n = 315), Streptococcus pneumoniae (n = 282), and Staphylococcus epidermidis (n = 176) collected at 16 Canadian microbiology laboratories from October 2000 to April 2001 were susceptible to linezolid. Future studies will determine how linezolid clinical use in Canada affects its in vitro activity.


2007 ◽  
Vol 51 (4) ◽  
pp. 1580-1581 ◽  
Author(s):  
James A. Karlowsky ◽  
Nancy M. Laing ◽  
Nachum Kaplan ◽  
Daryl J. Hoban ◽  
George G. Zhanel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document